Ustekinumab biosimilar (Bio-Thera ) |
BAT-2206 |
Phase 3 Clinical |
Bio-Thera Solutions Ltd |
Autoimmune Diseases; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis; Crohn Disease |
Details
|
Ustekinumab biosimilar(Formycon) |
FYB-202 |
Phase 3 Clinical |
|
Psoriasis |
Details
|
Lisofylline |
BL-194; CT-1501R; A-802710 |
Phase 3 Clinical |
Cti Biopharma Corp |
Diabetes Mellitus, Type 1; Rejection of organ transplantation |
Details
|
Ustekinumab Biosimilar (qyuns) |
QX-001-S; HDM-3001; QX-001S |
Phase 3 Clinical |
Qyuns Therapeutics Co Ltd |
Psoriasis; Plaque psoriasis |
Details
|
Ustekinumab Biosimilar(Celltrion) |
CT-P43 |
Phase 3 Clinical |
Celltrion Inc |
Psoriasis |
Details
|
Ustekinumab biosimilar(Biocon) |
|
Phase 3 Clinical |
Biocon Biologics Ltd |
Psoriasis |
Details
|
Ustekinumab biosimilar(CSPC Pharma) |
SYSA-1902 |
Phase 3 Clinical |
Jushi Biopharmaceutical Co Ltd |
Psoriasis; Plaque psoriasis |
Details
|
Apilimod mesilate |
AIT-101; STA-5326-mesylate; LAM-002; STA-5326; LAM-002A |
Phase 2 Clinical |
Synta Pharmaceuticals Corp, Lam |
Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid; Common Variable Immunodeficiency; Crohn Disease; Amyotrophic Lateral Sclerosis |
Details
|
NSC-733972 |
M-032; M032-H SV-1; NSC-733972 |
Phase 2 Clinical |
University Of Alabama At Birmingham |
Glioblastoma; Gliosarcoma; Astrocytoma |
Details
|
Tavokinogene telseplasmid (OncoSec Medical) |
pIL-12; DNA IL-12 |
Phase 2 Clinical |
Inovio Pharmaceuticals Inc |
Triple Negative Breast Neoplasms; Melanoma; Carcinoma, Hepatocellular; Mycosis Fungoides; Lung Neoplasms; Lymphoma, T-Cell, Cutaneous; Colorectal Neoplasms; Breast Neoplasms; Hepatitis B; Prostatic Neoplasms; Small Cell Lung Carcinoma; Hemorrhagic Fever, Ebola; Pancreatic Neoplasms; Neoplasms; Carcinoma, Merkel Cell; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; HIV Infections; Head and Neck Neoplasms; Ovarian Neoplasms |
Details
|
INO-9012/Human papillomavirus vaccine |
INO-3112; INO-9012/VGX-3100; VGX-3100/INO-9012 |
Phase 2 Clinical |
University Of Pennsylvania, Astrazeneca Plc, Inovio Pharmaceuticals Inc |
Squamous Cell Carcinoma of Head and Neck; Anus Neoplasms; Vaginal Neoplasms; Papillomavirus Infections; Neoplasms; Carcinoma, Transitional Cell; Vulvar Neoplasms; Oropharyngeal Neoplasms; Penile Neoplasms; Uterine Cervical Neoplasms |
Details
|
T-3011 |
T-3 (ImmVira Pharma); MVR-T3011; T3011; MVR-T3011 IT; MVR-T3011 IV; B015; B-015 |
Phase 2 Clinical |
Immvira Co Ltd |
Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Squamous Cell; Lymphoma; Endometrial Neoplasms; Lung Neoplasms; Colorectal Neoplasms; Sarcoma; Liver Neoplasms; Ascites; Mesothelioma; Small Cell Lung Carcinoma; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Head and Neck Neoplasms; Solid tumours; Ovarian Neoplasms |
Details
|
PDS-0301 |
M-9241; MSB-0010360; MSB0010360; PDS-0301 |
Phase 2 Clinical |
Emd Serono Inc, Merck Serono, National Cancer Institute |
Prostatic Neoplasms; Sarcoma, Kaposi; Uterine Cervical Neoplasms; Urogenital Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Oropharyngeal Neoplasms; Cholangiocarcinoma; Vulvar Neoplasms; Intestinal Neoplasms; Breast Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pancreatic Neoplasms; Papillomavirus Infections; Rectal Neoplasms; Carcinoma; Anus Neoplasms |
Details
|
STX-001 |
STX-001 |
Phase 2 Clinical |
Massachusetts Institute Of Technology |
Solid tumours |
Details
|
DF-6002 |
DF-6002 |
Phase 2 Clinical |
Dragonfly Therapeutics Llc |
Solid tumours; Neoplasms |
Details
|
Recombinant Human nsIL12 Oncolytic Adenovirus (Beijing Haute Biotechnology) |
BioTTT-001; BioTTT001 |
Phase 2 Clinical |
Beijing Bio-Targeting Therapeutics Technology Co Ltd |
Solid tumours; Stomach Neoplasms; Neoplasms; Colorectal Neoplasms |
Details
|
Recombinant Human IL12/15-PDL1B Herpes Simplex Type I Oncolytic Virus(CNBG) |
VG-161 |
Phase 2 Clinical |
Cnbg-Virogin Biotech (Shanghai) Ltd |
Solid tumours; Liver Neoplasms; Biliary Tract Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Pancreatic Neoplasms; Sarcoma; Cholangiocarcinoma; Carcinoma, Hepatocellular |
Details
|
Rocakinogene sifuplasmid |
INO-9012 |
Phase 2 Clinical |
Inovio Pharmaceuticals Inc |
Urogenital Abnormalities; Carcinoma, Hepatocellular; Precancerous Conditions; Lung Neoplasms; Vulvar Diseases; Hepatitis C; Colorectal Neoplasms; Squamous Intraepithelial Lesions of the Cervix; Breast Neoplasms; Prostatic Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Carcinoma, Transitional Cell; Liver Neoplasms; Neoplasms, Glandular and Epithelial; Papillomavirus Infections; Pancreatic Neoplasms; Glioblastoma; Esophageal Neoplasms; Stomach Neoplasms; Hemorrhagic Fever, Ebola; Hepatitis, Chronic; Head and Neck Neoplasms; HIV Infections; Ovarian Neoplasms |
Details
|
Veledimex |
INXN-1001; AD-1001 |
Phase 1 Clinical |
Ziopharm Oncology Inc |
Glioblastoma; Brain Neoplasms; Breast Neoplasms; Astrocytoma; Diffuse Intrinsic Pontine Glioma; Melanoma |
Details
|
XTX-301 |
XTX-301 |
Phase 1 Clinical |
|
Solid tumours; Neoplasms |
Details
|
VG-201 |
VG-201 |
Phase 1 Clinical |
ViroGin Biotech Ltd |
Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
VG-203 |
VG-203; VG2062; VG-2062 |
Phase 1 Clinical |
ViroGin Biotech Ltd, Shanghai Funuojian Biotechnology Co Ltd, Virogin Biotech (Shenzhen) Ltd, Fenojian Biotechnology (Nantong) Co Ltd |
Ovarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Breast Neoplasms |
Details
|
MVR-C5252 |
C-5252; MVR-C5252 |
Phase 1 Clinical |
Immvira Co Ltd |
Solid tumours; Ganglioglioma; Glioblastoma; Brain Neoplasms; Glioma |
Details
|
WTX-330 |
WTX-330 |
Phase 1 Clinical |
Werewolf Therapeutics Inc |
Solid tumours; Neoplasms; Lymphoma, Non-Hodgkin |
Details
|
WTX-124 |
WTX-124 |
Phase 1 Clinical |
Werewolf Therapeutics Inc |
Solid tumours; Neoplasm Metastasis |
Details
|
IL-12 DNA(NIAID) |
|
Phase 1 Clinical |
National Institute Of Allergy And Infectious Diseases (Niaid) |
HIV Infections |
Details
|
SW-0715 |
SW-0715 |
Phase 1 Clinical |
Stemirna Therapeutics |
Solid tumours |
Details
|
KGX-101 |
KGX-101; KGX101; KGX-101(IL-12-Fc融合蛋白); KGX-101(改造优化的细胞因子IL12前药分子) |
Phase 1 Clinical |
Shanghai KangaBio Co Ltd |
Solid tumours; Neoplasms |
Details
|
Ustekinumab Biosimilar (NeuClone/Serum Institute of India) |
|
Phase 1 Clinical |
Neuclone, Serum Institute Of India Ltd |
Autoimmune Diseases |
Details
|
TG-6050 |
TG-6050 |
Phase 1 Clinical |
Transgene Sa |
Carcinoma, Non-Small-Cell Lung |
Details
|
Ustekinumab biosimilar(Rani Therapeutics) |
RT-111 |
Phase 1 Clinical |
Rani Therapeutics Llc |
Psoriasis |
Details
|
ABOD-2011 |
ABOD-2011 |
Phase 1 Clinical |
Cancer Hospital Of Chinese Academy Of Medical Sciences |
Solid tumours |
Details
|
JCXH-211 |
JCXH-211 |
Phase 1 Clinical |
Jiachen Xihai(Hangzhou)Biotechnology Co Ltd |
Solid tumours; Skin Neoplasms |
Details
|
EGFR IL12 CART |
|
Phase 1 Clinical |
Shenzhen Prekin Biopharmaceutical Co Ltd |
Colorectal Neoplasms |
Details
|
XmAb-662 |
XmAb-662 |
Phase 1 Clinical |
Xencor Inc |
Solid tumours; Neoplasms |
Details
|
MEDI-1191 |
MEDI-1191; MEDI1191 |
Phase 1 Clinical |
Moderna Inc |
Solid tumours; Neoplasms |
Details
|
Ustekinumab biosimilar (BioFactura) |
BFI-751 |
Phase 1 Clinical |
BioFactura Australia Pty Ltd |
Psoriasis |
Details
|
MEDI-9253 |
|
Phase 1 Clinical |
Astrazeneca Plc |
Solid tumours; Neoplasms |
Details
|
INXN-2001 |
Ad-IL-12; ZIN-ATI-001; Ad-RTS-hIL-12; Ad-RTS-mIL-12; INXN-2001; Ad-RTS-IL-12; INXN-2001 (Ad-RTS-IL-12) |
Phase 1 Clinical |
Ziopharm Oncology Inc |
Glioblastoma; Breast Neoplasms; Brain Neoplasms; Diffuse Intrinsic Pontine Glioma; Astrocytoma; Melanoma |
Details
|
Ustekinumab biosimilar (Bio-Thera ) |
BAT-2206 |
Phase 3 Clinical |
Bio-Thera Solutions Ltd |
Autoimmune Diseases; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis; Crohn Disease |
Details
|
Ustekinumab biosimilar(Formycon) |
FYB-202 |
Phase 3 Clinical |
|
Psoriasis |
Details
|
Lisofylline |
BL-194; CT-1501R; A-802710 |
Phase 3 Clinical |
Cti Biopharma Corp |
Diabetes Mellitus, Type 1; Rejection of organ transplantation |
Details
|
Ustekinumab Biosimilar (qyuns) |
QX-001-S; HDM-3001; QX-001S |
Phase 3 Clinical |
Qyuns Therapeutics Co Ltd |
Psoriasis; Plaque psoriasis |
Details
|
Ustekinumab Biosimilar(Celltrion) |
CT-P43 |
Phase 3 Clinical |
Celltrion Inc |
Psoriasis |
Details
|
Ustekinumab biosimilar(Biocon) |
|
Phase 3 Clinical |
Biocon Biologics Ltd |
Psoriasis |
Details
|
Ustekinumab biosimilar(CSPC Pharma) |
SYSA-1902 |
Phase 3 Clinical |
Jushi Biopharmaceutical Co Ltd |
Psoriasis; Plaque psoriasis |
Details
|
Apilimod mesilate |
AIT-101; STA-5326-mesylate; LAM-002; STA-5326; LAM-002A |
Phase 2 Clinical |
Synta Pharmaceuticals Corp, Lam |
Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid; Common Variable Immunodeficiency; Crohn Disease; Amyotrophic Lateral Sclerosis |
Details
|
NSC-733972 |
M-032; M032-H SV-1; NSC-733972 |
Phase 2 Clinical |
University Of Alabama At Birmingham |
Glioblastoma; Gliosarcoma; Astrocytoma |
Details
|
Tavokinogene telseplasmid (OncoSec Medical) |
pIL-12; DNA IL-12 |
Phase 2 Clinical |
Inovio Pharmaceuticals Inc |
Triple Negative Breast Neoplasms; Melanoma; Carcinoma, Hepatocellular; Mycosis Fungoides; Lung Neoplasms; Lymphoma, T-Cell, Cutaneous; Colorectal Neoplasms; Breast Neoplasms; Hepatitis B; Prostatic Neoplasms; Small Cell Lung Carcinoma; Hemorrhagic Fever, Ebola; Pancreatic Neoplasms; Neoplasms; Carcinoma, Merkel Cell; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; HIV Infections; Head and Neck Neoplasms; Ovarian Neoplasms |
Details
|
INO-9012/Human papillomavirus vaccine |
INO-3112; INO-9012/VGX-3100; VGX-3100/INO-9012 |
Phase 2 Clinical |
University Of Pennsylvania, Astrazeneca Plc, Inovio Pharmaceuticals Inc |
Squamous Cell Carcinoma of Head and Neck; Anus Neoplasms; Vaginal Neoplasms; Papillomavirus Infections; Neoplasms; Carcinoma, Transitional Cell; Vulvar Neoplasms; Oropharyngeal Neoplasms; Penile Neoplasms; Uterine Cervical Neoplasms |
Details
|
T-3011 |
T-3 (ImmVira Pharma); MVR-T3011; T3011; MVR-T3011 IT; MVR-T3011 IV; B015; B-015 |
Phase 2 Clinical |
Immvira Co Ltd |
Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Squamous Cell; Lymphoma; Endometrial Neoplasms; Lung Neoplasms; Colorectal Neoplasms; Sarcoma; Liver Neoplasms; Ascites; Mesothelioma; Small Cell Lung Carcinoma; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Head and Neck Neoplasms; Solid tumours; Ovarian Neoplasms |
Details
|
PDS-0301 |
M-9241; MSB-0010360; MSB0010360; PDS-0301 |
Phase 2 Clinical |
Emd Serono Inc, Merck Serono, National Cancer Institute |
Prostatic Neoplasms; Sarcoma, Kaposi; Uterine Cervical Neoplasms; Urogenital Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Oropharyngeal Neoplasms; Cholangiocarcinoma; Vulvar Neoplasms; Intestinal Neoplasms; Breast Neoplasms; Urinary Bladder Neoplasms; Prostatic Neoplasms, Castration-Resistant; Pancreatic Neoplasms; Papillomavirus Infections; Rectal Neoplasms; Carcinoma; Anus Neoplasms |
Details
|
STX-001 |
STX-001 |
Phase 2 Clinical |
Massachusetts Institute Of Technology |
Solid tumours |
Details
|
DF-6002 |
DF-6002 |
Phase 2 Clinical |
Dragonfly Therapeutics Llc |
Solid tumours; Neoplasms |
Details
|
Recombinant Human nsIL12 Oncolytic Adenovirus (Beijing Haute Biotechnology) |
BioTTT-001; BioTTT001 |
Phase 2 Clinical |
Beijing Bio-Targeting Therapeutics Technology Co Ltd |
Solid tumours; Stomach Neoplasms; Neoplasms; Colorectal Neoplasms |
Details
|
Recombinant Human IL12/15-PDL1B Herpes Simplex Type I Oncolytic Virus(CNBG) |
VG-161 |
Phase 2 Clinical |
Cnbg-Virogin Biotech (Shanghai) Ltd |
Solid tumours; Liver Neoplasms; Biliary Tract Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Pancreatic Neoplasms; Sarcoma; Cholangiocarcinoma; Carcinoma, Hepatocellular |
Details
|
Rocakinogene sifuplasmid |
INO-9012 |
Phase 2 Clinical |
Inovio Pharmaceuticals Inc |
Urogenital Abnormalities; Carcinoma, Hepatocellular; Precancerous Conditions; Lung Neoplasms; Vulvar Diseases; Hepatitis C; Colorectal Neoplasms; Squamous Intraepithelial Lesions of the Cervix; Breast Neoplasms; Prostatic Neoplasms; Small Cell Lung Carcinoma; Neoplasms; Carcinoma, Transitional Cell; Liver Neoplasms; Neoplasms, Glandular and Epithelial; Papillomavirus Infections; Pancreatic Neoplasms; Glioblastoma; Esophageal Neoplasms; Stomach Neoplasms; Hemorrhagic Fever, Ebola; Hepatitis, Chronic; Head and Neck Neoplasms; HIV Infections; Ovarian Neoplasms |
Details
|
Veledimex |
INXN-1001; AD-1001 |
Phase 1 Clinical |
Ziopharm Oncology Inc |
Glioblastoma; Brain Neoplasms; Breast Neoplasms; Astrocytoma; Diffuse Intrinsic Pontine Glioma; Melanoma |
Details
|
XTX-301 |
XTX-301 |
Phase 1 Clinical |
|
Solid tumours; Neoplasms |
Details
|
VG-201 |
VG-201 |
Phase 1 Clinical |
ViroGin Biotech Ltd |
Solid tumours; Stomach Neoplasms; Esophageal Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
VG-203 |
VG-203; VG2062; VG-2062 |
Phase 1 Clinical |
ViroGin Biotech Ltd, Shanghai Funuojian Biotechnology Co Ltd, Virogin Biotech (Shenzhen) Ltd, Fenojian Biotechnology (Nantong) Co Ltd |
Ovarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Breast Neoplasms |
Details
|
MVR-C5252 |
C-5252; MVR-C5252 |
Phase 1 Clinical |
Immvira Co Ltd |
Solid tumours; Ganglioglioma; Glioblastoma; Brain Neoplasms; Glioma |
Details
|
WTX-330 |
WTX-330 |
Phase 1 Clinical |
Werewolf Therapeutics Inc |
Solid tumours; Neoplasms; Lymphoma, Non-Hodgkin |
Details
|
WTX-124 |
WTX-124 |
Phase 1 Clinical |
Werewolf Therapeutics Inc |
Solid tumours; Neoplasm Metastasis |
Details
|
IL-12 DNA(NIAID) |
|
Phase 1 Clinical |
National Institute Of Allergy And Infectious Diseases (Niaid) |
HIV Infections |
Details
|
SW-0715 |
SW-0715 |
Phase 1 Clinical |
Stemirna Therapeutics |
Solid tumours |
Details
|
KGX-101 |
KGX-101; KGX101; KGX-101(IL-12-Fc融合蛋白); KGX-101(改造优化的细胞因子IL12前药分子) |
Phase 1 Clinical |
Shanghai KangaBio Co Ltd |
Solid tumours; Neoplasms |
Details
|
Ustekinumab Biosimilar (NeuClone/Serum Institute of India) |
|
Phase 1 Clinical |
Neuclone, Serum Institute Of India Ltd |
Autoimmune Diseases |
Details
|
TG-6050 |
TG-6050 |
Phase 1 Clinical |
Transgene Sa |
Carcinoma, Non-Small-Cell Lung |
Details
|
Ustekinumab biosimilar(Rani Therapeutics) |
RT-111 |
Phase 1 Clinical |
Rani Therapeutics Llc |
Psoriasis |
Details
|
ABOD-2011 |
ABOD-2011 |
Phase 1 Clinical |
Cancer Hospital Of Chinese Academy Of Medical Sciences |
Solid tumours |
Details
|
JCXH-211 |
JCXH-211 |
Phase 1 Clinical |
Jiachen Xihai(Hangzhou)Biotechnology Co Ltd |
Solid tumours; Skin Neoplasms |
Details
|
EGFR IL12 CART |
|
Phase 1 Clinical |
Shenzhen Prekin Biopharmaceutical Co Ltd |
Colorectal Neoplasms |
Details
|
XmAb-662 |
XmAb-662 |
Phase 1 Clinical |
Xencor Inc |
Solid tumours; Neoplasms |
Details
|
MEDI-1191 |
MEDI-1191; MEDI1191 |
Phase 1 Clinical |
Moderna Inc |
Solid tumours; Neoplasms |
Details
|
Ustekinumab biosimilar (BioFactura) |
BFI-751 |
Phase 1 Clinical |
BioFactura Australia Pty Ltd |
Psoriasis |
Details
|
MEDI-9253 |
|
Phase 1 Clinical |
Astrazeneca Plc |
Solid tumours; Neoplasms |
Details
|
INXN-2001 |
Ad-IL-12; ZIN-ATI-001; Ad-RTS-hIL-12; Ad-RTS-mIL-12; INXN-2001; Ad-RTS-IL-12; INXN-2001 (Ad-RTS-IL-12) |
Phase 1 Clinical |
Ziopharm Oncology Inc |
Glioblastoma; Breast Neoplasms; Brain Neoplasms; Diffuse Intrinsic Pontine Glioma; Astrocytoma; Melanoma |
Details
|